Follow-up care of 12 months of patients with bladder cancer in Spain : A multicenter prospective cohort study
Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau)
Martinez-Zapata, Maria José (Institut d'Investigació Biomèdica Sant Pau)
Barrionuevo-Rosas, Leslie (Centro Cochrane Iberoamericano)
Vernooij, Robin W. M. (Centro Cochrane Iberoamericano)
Sánchez, María José (Instituto de Investigación Biosanitaria de Granada)
Morales-Suárez-Varela, María (Universitat de València)
De la Cruz, Javier (Hospital Universitario 12 de Octubre (Madrid))
Emparanza, José Ignacio (Biodonostia Osasun Ikerketako Institutura (País Basc))
Ferrer Forés, Maria Montserrat (Institut Hospital del Mar d'Investigacions Mèdiques)
Pijoan, José Ignacio (Hospital Universitario de Cruces (Barakaldo, País Basc))
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau)
Frances, Albert (Hospital Ntra. Sra. Del Mar)
Madrid, Eva (Centro Cochrane Iberoamericano)
Coscia, Claudia (Barts and the London School of Medicine and Dentistry. Queen Mary University London)
Zamora, Javier (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid))
Universitat Autònoma de Barcelona

Date:	2022
Abstract:	The therapeutic approach of bladder cancer strongly determines its prognosis. We describe the treatments and outcomes for a Spanish cohort of patients with bladder cancer for the first 12 months after diagnosis and identify the factors that influenced the decision to undergo the treatment received. We conducted a multicenter, prospective, cohort study including primary bladder cancer patients during the first 12 months after diagnosis. The clinical outcomes were performance status (ECOG), adverse events and any cause of mortality. We stratified the analysis by factors that might influence the treatments received. We conducted univariate and multivariable logistic regression models to assess which patient and tumor characteristics were associated with receiving adjuvant treatment in the subgroup of noninvasive bladder cancer patients. In total, 314 patients were included (85% men; 53. 8%.
Grants:	Ministerio de Ciencia e Innovación PS09/01204 Ministerio de Ciencia e Innovación PS09/01619 Instituto de Salud Carlos III CP1120/00023
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Bladder neoplasms ; Cohort study ; Male urogenital diseases ; Multicenter study ; Multivariable analysis
Published in:	Medicine, Vol. 101 Núm. 42 (October 2022) , p. E31175, ISSN 1536-5964

DOI: 10.1097/MD.0000000000031175
PMID: 36281169

8 p, 515.5 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles